Medgenics Share Discussion Threads

[sicilian_kan] 15/9/2013 16:54

Don't forget to include the massive number of warrants and options...

[fanboy1] 15/9/2013 16:50

Ok thanks PDT.

[pdt] 15/9/2013 13:21

At 30 June the latest report says there were 18.4 million shares in issue. So at 4 dollars a share the market cap looks around 74 million dollars. Deduct the 29 million in cash and you are left with 45 million or £30 million value for the business. I am assuming that covers all listings, at least that is how I am reading it but I may be wrong.

[fanboy1] 14/9/2013 20:12

Got to agree. Can anyone help with what the current valuation of this company actually is? Bit confused with the MEDU, MEDG, and MDGN.

[pdt] 14/9/2013 18:43

I added to my holding at the end of last week. We must be close to getting news on the US trials and I think we are due some interim data on the Hepatitis C trials in Israel before year end as well. Given the amount of cash on the balance sheet and the current valuation my own view is that the risk to the downside has to be limited so worth a gamble at this price.

[237gmoney] 10/9/2013 09:16

A bit odd that the share price went down over here on next to no trades yet went up in USA. just a small blip. Would be nice to get news of these US Trials though

[fanboy1] 02/9/2013 12:19

Yeah I know we look in good shape for next year I should probably just forget about this one for a bit. US Trials would be quite nice to get the interest rolling. Seems strange share price dropping off over in the US atm even though that announcement is anticipated.

It's always positive news and after inspecting the last results a bit we actually look in really good shape compared to when the share price was c£9.15. Just wish management were a bit more vocal.

Despite that I will probably top up in the next month or so if we still have no news and share price falls further - I don't want to catch a falling knife but I don't think that's what this is.

Fanboy.

[237gmoney] 02/9/2013 09:51

Yes agree FB it is frustrating but this company requires bundles of patience. Next year will be the big year for this outfit but still hoping for an uplift in share price with the announcement of the US Trials.

They mentioned they would start in the 2nd half of the year and most likely Q4 but still hoping they are announced this month.

[fanboy1] 02/9/2013 09:27

Frustrating lack of interest still in this share. Really hoping for some news soon or the % gain required to get me back to break-even will be even more ridiculous than it is already!!

Patience I know..

[count chris] 19/8/2013 22:11

It does seem a fantastic treatment as long as the price is right

[237gmoney] 19/8/2013 15:10

Found this posted on a website today....goes to show that people around the world are all waiting for Medgenics to come through with their new method of taking EPO. It will literally change the lives for everyone concerned.

Translated from Arabic to english so not perfect but you get the message

"...my sister who is 4 years older than me just had to reexplain this to her doctor This condition is called nonspherocytic hemolytic anemia When Medgenics lastly comes through clinical trials with a safe, non new medication method of treating the actual anemia from unbearable condition of chronic renal system disease, not only the FDA but doctors around the world will Inhale a sigh of relief, finally able to provide patients something that is not likely to kill them..."


hxxp://www.mekyaj.net/vb/showthread.php?t=39878

[237gmoney] 15/8/2013 10:07

A week has passed since the results and still more buys trickle in. Slow and steady but everyday we have something.

It can't be much longer before they announce when the US Trials will be launched and where. The question is will there be a partner onboard and will they be putting some money upfront?

Whatever way you look at it the next few weeks I can only see upside here.

[237gmoney] 09/8/2013 14:58

Buys outweigh sells since the results, can't be long before they have to mark this up. Hopefully we hear news of the US Trials before the end of August

[237gmoney] 06/8/2013 15:00

Overall Q2 results in line with expectations and nice to see the company still have $30m cash in the bank.

This company should be fully funded right through 2014 now and also they plan no go into partnership agreements with third parties for the the biopumps and also the US clinical trials.

Hopefully news of the US trails is not too far away which should lift the share price. I see in the MD&A the company hired a consultant in June for 24 months at a cost of 100k shares. The company also employed other consultants earlier on in the year and were also given shares as payment.

It is therefore in their best interests that the share price rises from here on in.

[237gmoney] 06/8/2013 14:54

Medgenics net losses narrow
6 August 2013 | 14:32pm

StockMarketWire.com - Medgenics posts net losses of $5.78m for the six months to the end of June - down from $9.66m last time.

Gross R&D expense for the first half of 2013 increased to $4.10m from $3.23m for corresponding period in 2012 due to an increase in R&D personnel.

Net R&D expense for the first half of 2013 was $2.89m compared with net R&D expense of $1.75m for the first half of 2012.

General and administrative expenses were $4.13m - consistent with the prior-year period.

- See more at: hxxp://www.stockmarketwire.com/article/4646026/Medgenics-net-losses-narrow.html#sthash.FgFN6xZl.dpuf

[fanboy1] 31/7/2013 14:55

That seems pretty agreeable, thanks for responding.

[237gmoney] 31/7/2013 14:26

I would hold out for at least the Q2 results and the announcement of the US Trials. That will spur on interest in the company again and we should see a spike in the share price to 350/400p again.

What price next Year? Thats a difficult one as next year is a pivotal year for the company especially in H1 2014 with potential results of the US Trials and possible ramp up towards full production of the biopumps.

I fully believe someone like Baxters will come back in for Medgenics and the founders/owners will not give this away for anything less than $1 billion. So your talking of a price 6/7 times greater than what we have today but who knows.

[fanboy1] 31/7/2013 14:11

Any thoughts to a realistic target price for this next year? I've been tempted to ditch lately and just need some rampers to make me think everything is alright.

[237gmoney] 29/7/2013 10:22

I found this snippet on a website last week...

hxxp://www.cpreports.com/2013/07/22/market-alert-wall-street-rumblings-clxiv-july-14-2013-by-ray-dirks/

Market Alert: Wall Street Rumblings # CLXIV July 21, 2013 by Ray Dirks
Posted on admin on July 22, 2013 // Leave Your Comment


MARKET ALERT – Rumblings Up, Down, and Around Wall Street Issue #CLXIV, dated July 21st, 2013 featuring RAY DIRKS Research with Ray Dirks and his team of Money Managers and Security Analysts, in association with the internationally followed Web Sites – www.CorporateProfile.com and www.CPreports.com, where Fashion meets Finance, and where Stocks meet Blonds.

Last week, ending July 19th, was another big week for Rumblings as several our Favorite Stocks for 2013 advanced sharply – notably Medgenics (MDGN), which was the 4th biggest gainer on the AMEX last week, according to Barron's, The Dow Jones Business and Financial Weekly – up 17.3% to $4.74. Ray Dirks and his team has been recommending MDGN in its Articles over the past several months for its substantial capital appreciation potential over the Short Term (6 to 9 months) and the Long Term (1 to 2 years).

Medgenics is a biotechnology and medical therapeutics company that is making significant progress in the development and commercialization of several proprietary platforms, including Biopump, for the production and delivery of therapeutic proteins using the patient's own tissue in the treatment of a range of chronic diseases, including anemia, hemophilia, and hepatitis. On Tuesday, July, 16th, the Office of The Chief Scientist (OCS) of the Ministry of Trade, Labor, and Industry of Israel announced the award of a $1.9 Million grant to Medgenics to move the platform ahead rapidly.

[237gmoney] 23/7/2013 09:43

Apparently the management team of Medgenics are going to meet with Oppenheimer Asset Management soon.

Meeting to be held in New York on July 24 hosted by Oppenheimer.

Why would they set up a meeting with an Asset Management company unless another company wanted to buy a stake in the firm?

Interesting development...

hxxp://www.theflyonthewall.com/permalinks/entry.php/MDGNid1861105/MDGN-Medgenics-management-to-meet-with-Oppenheimer

[jammytass] 20/7/2013 05:56

good trial results on the cards !!!!

[237gmoney] 19/7/2013 16:36

Currently up 6% in the US today - 8th straight blue day. Quite a turn around in the last two weeks and I think the company is gearing up for a strong finish to the end of the year.

I just got a sense from the last presentation at the JMP healthcare conference that the CEO seemed really positive about the current prospects here and after 10 years working on the Biopump and the technology surrounding it, you can sense that it is all coming together now.

It will be interesting to see what happens with the US trials as it appears a deal is in place and they are just putting the final touches to it. With over $30m in the bank still there is no funding issues and potentially if a joint partner is coming on board then they may well have to put up some money upfront.

We will see.

[fanboy1] 19/7/2013 13:35

I don't think we should be going to 190p this time but you never know. Would love some news/updates - this share lacks any real market interest over here with tiny/zero volume it needs a spark!

[237gmoney] 18/7/2013 16:47

Some nice buys today. This will pick up pace soon with the Q2 results only a couple of weeks away. Going for a 7th straight blue day in the US and hopefully some good news to come.

[237gmoney] 18/7/2013 00:24

6 straight blue days now in the US so it appears the stock has turned the corner over there. When the company do announce the US trails for which they already have an IND there will be a very positive reaction here imo.

If you listen to the JMP presentation, the CEO comes across very positive about the future of where this company is going. They now have all their ducks in place and are ready to this company to the masses.

The next few months should be very interesting indeed.